UC-II

Best for

Reduce pain and daily disability

Large effect, needs confirmation · 40 mg/day for 12 weeks · 1 study , n=60

5 papers · 6 claims · 18 outcomes scored · 5 positive

Outcomes

What uc-ii actually does, by outcome

Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.

Outcome Effect size Evidence Dose Weeks Rank

Reduce pain and daily disability Large effect, needs confirmation

Pain gets in the way less so you move, work, and rest more freely.

1 RCT n=60 40 mg 12 wk #2/5

36562843

large

1 RCT n=60

40 mg

12 wk

#2 /5

Loosen stiff joints Faint early signal

Joints move more freely, especially after rest or first thing in the morning.

3 RCTs n=266 40 mg 12–26 wk #6/9

26822714·36562843·35377244

small

3 RCTs n=266

40 mg

12–26 wk

#6 /9

Ease joint pain Faint early signal

Your joints stop being the first thing you notice every morning.

3 RCTs n=214 40 mg 9–26 wk #2/18

24153020·26822714·36562843

small

3 RCTs n=214

40 mg

9–26 wk

#2 /18

Ease arthritis pain and joint inflammation Likely real but unnoticeable

Less pain, less stiffness, quieter inflammatory signals inside the joint.

4 RCTs n=282 40–960 mg 9–26 wk #5/21

26822714·36562843·40897777·24153020

trivial

4 RCTs n=282

40–960 mg

9–26 wk

#5 /21

Reduce everyday pain intensity Not enough research

Lower intensity, fewer flares, and longer stretches of relief.

2 RCTs n=189 40–960 mg 12–26 wk

40897777·26822714

trivial

2 RCTs n=189

40–960 mg

12–26 wk

—

Slow cartilage wear in knee arthritis Not enough research

Your cartilage holds its structure longer instead of quietly dissolving.

1 RCT n=106 40 mg 26 wk #9/9

26822714

—

1 RCT n=106

40 mg

26 wk

#9 /9

Outcome	Effect	Evidence	Dose	Weeks	Rank
Reduce pain and daily disability Large effect, needs confirmation	large	1 RCT n=60	40 mg	12 wk	#2/5
Loosen stiff joints Faint early signal	small	3 RCTs n=266	40 mg	12–26 wk	#6/9
Ease joint pain Faint early signal	small	3 RCTs n=214	40 mg	9–26 wk	#2/18
Ease arthritis pain and joint inflammation Likely real but unnoticeable	trivial	4 RCTs n=282	40–960 mg	9–26 wk	#5/21
Reduce everyday pain intensity Not enough research	trivial	2 RCTs n=189	40–960 mg	12–26 wk	—
Slow cartilage wear in knee arthritis Not enough research		1 RCT n=106	40 mg	26 wk	#9/9

Buy well

Recommended UC-II products

Real products that dose UC-II where the research does, in a clean formulation, from brands we've audited. We only list ones we'd stand behind.

Chosen for adequate UC-II dosing vs. the studied range, a clean formulation (grade A–C), and independent brand-quality audits. Not sponsored.

Risk profile

Adverse events and known drug interactions

Safety events

gastrointestinal discomfort (dyspepsia, flatulence, reflux esophagitis, appetite loss) mild

skin irritation mild

Sources

Generated August 14, 2026